These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 31650979

  • 1. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E, Kanelleas A, Nikolakopoulos S, Bezrodnii G, Nearchou E, Gerodimou M, Papadopoulou-Skordou E, Paparizos V, Rigopoulos D.
    Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W.
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [Abstract] [Full Text] [Related]

  • 4. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A, Monsonego J, Moyal-Barracco M, Pribil C.
    Ann Dermatol Venereol; 2003 Mar; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
    Gross G.
    Hautarzt; 2001 Jan; 52(1):6-17. PubMed ID: 11220242
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
    Bonnez W, Elswick RK, Bailey-Farchione A, Hallahan D, Bell R, Isenberg R, Stoler MH, Reichman RC.
    Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.
    Tyring S, Edwards L, Cherry LK, Ramsdell WM, Kotner S, Greenberg MD, Vance JC, Barnum G, Dromgoole SH, Killey FP, Toter T.
    Arch Dermatol; 1998 Jan; 134(1):33-8. PubMed ID: 9449907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.